FDA Cracks Down On Spas' Lipodissolve Claims

Law360, New York (April 8, 2010, 1:14 PM EDT) -- The U.S. Food and Drug Administration has warned six U.S. medical spas and a company in Brazil to remove false or misleading statements from their Web sites about a procedure called “lipodissolve” intended to eliminate fat.

The FDA said Wednesday that it had received reports of people who suffered adverse effects from the procedure, including permanent scarring, skin deformation, and deep, painful knots under the skin. The drugs used in the lipodissolve procedures have not been evaluated or approved by the FDA for that particular use,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.